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* and Jean Weiss
 a
* 
Abstract: The association of hydrophobic cavities with porphyrin derivatives has been used to mimic haemoprotein 
structures. The most employed cavity in this field is β-cyclodextrin (β-CD) and scaffolds combining β-CDs and porphyrins 
are expected to inspire the combination of porphyrins and cucurbiturils in a near future. Aside from providing water 
solubility to various porphyrinic structures, the β-CD framework can also modulate and control the reactivity of the metal 
core of the porphyrin. After a general introduction of the challenges faced in the field of haemoprotein models and the 
binding behavior of β-CDs, the article will discuss covalent and non-covalent association of porphyrins with β-CDs. In each 
approach, the role of the CD differs according to the relative position of the concave CD host, either directly controlling the 
binding and transformation of a substrate on the metalloporphyrin or playing a dual role of controlling the water solubility 
and selecting the axial ligand of the metal core. The discussion will be of interest to the cucurbituril community as well as 
to the cavitand community as the information provided should be useful for the design of haemoprotein mimics using 
cucurbiturils (CBs). 
Introduction 
Understanding molecular functions in natural systems is 
the origin of the bio-inspired chemistry research field. Due to 
their implication in a wide range of biological processes, 
haemoproteins, in which the properties of an iron porphyrin 
(heme) derivative are controlled by the hydrophobic pocket of 
a globular polypeptide (globin), have been extensively 
studied.
1
 From the initial challenge addressing the difference 
between the distal face vs proximal face (Figure 1)
2
 in the 
binding of exogenic ligands
3
 to Fe
II
,to the design of elaborate 
capped architectures, this field has become strongly 
dependent on the synthetic chemist’s abilities to produce 
finely tuned structures that mimic protein active sites.
4
 Thus, 
under the pressure of rapid publishing and fast, intellectually 
rewarding projects, the field of haemoprotein models slowly 
seems to reach a conceptual dead-end due to the extreme 
sophistication of protein models and the endless synthetic 
efforts associated with stepwise functionalization of an active 
catalytic heme.
5
 Whereas the combination of concave subunits 
with transition metal-based catalysts has emerged as a 
promising method to control the topography of substrate-
metal interactions during a transformation,
6
 the combination 
of concave hosts with heme platforms has somehow been 
underexploited and so far restricted to the use of 
cyclodextrins. Among the concave platforms commonly used 
in supramolecular chemistry, cyclodextrins (CDs) share with 
cucurbiturils (CBs) an intrinsic water solubility that is very 
interesting for the development of bio-inspired models 
operating in physiological medium.  
For the sake of clarity, Figure 2 summarizes the noteworthy 
positions located on a tetraphenylporphyrin and provides a 
general drawing of a cyclodextrin. In porphyrins, “meso” refers 
to the position at the methylene bridge between two pyrrolic 
units. The labels “o”, “m” and “p” indicate positions on an 
aromatic ring at the meso position. Although most of the work 
discussed hereafter deals with β-CDs, the general formula of a 
CD is represented in Figure 2, where n = 0 corresponds to an α-
CD, n = 1 to a β-CD and n = 2 to a γ-CD. 
 
Figure 1. Representation of oxygenated myoglobin (PDB#1MBO) showing the influence 
of the distant histidine 64 (top) and the direct binding of the proximal histidine 93 
(bottom). 
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Figure 2. a) Schematic structure of a tetra-aryl porphyrin and labeling of noteworthy 
positions; b) Generic structure of cyclodextrins and differentiation of the primary and 
secondary faces. 
The next pages will focus on porphyrin-cyclodextrin 
architectures that could be inspirational for the development 
of new haemoprotein models, artificial enzymes and water-
soluble catalysts. Architectures leading to electronic 
interactions between a photoactive porphyrin and either a CD
7
 
or a guest in the CD
8,9
 are out of scope of this article due to the 
intrinsic inertness of hemes; however, information can be 
found in relevant leading references cited above. In some 
cases, porphyrin-cyclodextrin conjugates have been used for 
biomedical applications in which the CD subunit is used as a 
drug carrier until its release is triggered by applying a stimulus 
to the porphyrin.
10
 Again, due to weak relevance in terms of 
haemoprotein models, these scaffolds will not be discussed 
but information can be found in the reference section of 
selected publications.
10-11
  
As always, two approaches, one covalent and the other 
non-covalent, have been developed to combine cyclodextrins 
and porphyrins.  The cartoons in Figure 3 depict various 
positions of the CD moieties observed in cyclodextrin(s)/heme 
conjugates (A-F). All but two (E and F) feature covalent 
bonding between the CD(s) and the porphyrin. The properties 
of the scaffolds will be discussed in sections arranged as a 
function of the covalent or non-covalent link between the 
porphyrin and the cyclodextrin(s).  
Covalent porphyrin-CD(s) conjugates 
In general, covalent linkages between the porphyrin and 
the cyclodextrin are connected to the primary face of the CDs, 
due to synthetic issues. This consideration is rather important 
in regard to the difficult functionalisation of cucurbiturils. As 
pointed out by several experts in the field, the modification of 
CBs is mostly restricted to the introduction of a single 
function.
12
 Thus, the design of covalent conjugates of type A, B 
or C is already feasible by replacing the CDs by CBs.
 12b
  
The first type A conjugate was reported in 1982 by 
Kobayashi and consisted in a scaffold comprising a β-CD linked 
to a meso-tritolyl-o-hydroxyphenyl-porphyrin derivative by an 
ester bridge (Figure 4).
13
 The drawback of classical 
haemoprotein models,
3
 namely their poor solubility in water, 
was pointed out in the introduction of the paper and 
magnetically induced circular dichroism (MCD) studies of the 
corresponding Fe-porphyrin showed that conformational 
changes in water (vs DMSO) correlated with interactions 
between the porphyrin and the CD. However, no evidence for 
functional mimicry of haemoprotein was observed.  
 
Figure 3. Cartoons depicting reported porphyrin-CD scaffolds assembled by covalent 
links with mono-functionalized CDs (A-C), di-functionalized CDs (D), or non-covalent 
bonding (E,F).  
Although unrelated to haemoprotein models, it is worth 
mentioning that a similar structure, with a β-cyclodextrin and a 
meso-tritolyl-p-benzoato-porphyrin, was described soon after 
by Weedon.
14
 The p-position of the linker forbid the folding 
that brings the porphyrin in contact with the cyclodextrin and 
thus separates an electron donating Zn-porphyrin and an 
electron accepting guest in the CD, enhancing the lifetime of a 
charge separated state after excitation of the Zn-porphyrin.  
 
 
 
Figure 4. The first covalent porphyrin-CD scaffold reported in the literature. 
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These two examples of type A scaffolds, and especially the 
electron transfer properties described in the last example 
initiated a field of study concerning biomedicinal applications 
using photoactive porphyrin derivatives (non “heme”) and 
guests in the CDs that are out of the scope of this article, but 
can nevertheless be applied to mono-functionalised 
cucurbiturils. As far as catalytic activity is concerned, the 
concept has been extended to Mn-porphyrins for the 
investigation of superoxide dismutase (SOD) activity using a β-
CD derivative connected by an ether link to the p position of a 
MnTPP.
15
 The SOD activity was 15 times higher in the 
conjugate than in the reference compounds. In addition, the 
enhancement in activity is greater than that observed in a 
simultaneously reported Mn-salophen/β-CD conjugate. This 
non-hemic approach and the reactivity of Mn-porphyrins was 
also exploited using α-CDs conjugated with MnTPP, which acts 
as a clamp-like catalyst. The presence of the CD host enhances 
the proximity between a polybutadiene substrate and the Mn 
catalytic site. The presence of the CD (α or β) favours the 
formation of trans-epoxides, whereas replacement of the CD 
by its permethylated analogue inverts the selectivity to favour 
the cis-epoxides, a typical behaviour of MnTPP alone.
16
 
Thus, in the case of a single covalent link in o, m or p 
positions between a porphyrin and a CD, the influence and 
effect of the CD can be hard to assess or hard to interpret due 
to a less preorganized scaffolding. To achieve a higher level of 
organisation in the porphyrin-CD conjugates, the number of 
either links or recognition points needs to be increased. 
Increasing the number of hosts in type B or C architectures will 
allow the positioning of a substrate recognised at its 
extremities by the CD units on top of a Fe-porphyrin, inducing 
a regioselective character in the interactions between the iron 
centre and the substrate. The use of multiple connections 
allows the CDs to control the access to the metallic core of the 
Fe-porphyrin in type D scaffolds. In this case, substrate 
selection and folding may induce regioselectivity in the 
interactions with the iron porphyrin core. Both strategies are 
discussed chronologically in the next paragraphs. 
Surprisingly, the first approach that was developed 
combined difunctionalized CDs and tetrafunctionalized 
porphyrins, leading to a type D scaffold. In 1991, the 
lipoxygenase-like activity of a porphyrin sandwiched between 
two β-CDs (Scheme 1) was reported by Kuroda.17 The CD is 
linked to the free base of TPP by thioether bridges in o 
positions of the aromatic meso substituents of the porphyrin. 
The nearly fourfold symmetry of the scaffold renders the 
synthesis less difficult than for type B scaffolds and positions 
the CD cavity on top of the porphyrin centre. The porphyrin is 
used as a sensitizer to generate singlet oxygen able to oxidize 
the unsaturated bonds of an unsymmetrical diene.  
Due to the structure of the CDs, the scaffold exists as a 
mixture of isomers that are used together as hosts during the 
oxidation of the substrates depicted in Scheme 1.  In 
comparison to results obtained with free base tetrakis(p-
sulphonatophenyl)porphyrin (H2TPPS) or a mixture of non-
linked H2TPPS and β-CD that generates mostly the conjugated 
dienes a and d with the same specificities, the porphyrin-CD 
assembly shows a clear regio-selectivity for the oxidation at 
the 12-13 bond. In this pioneering work, the use of a 
stoichiometric amount of the porphyrin-CD assembly seems 
required to maximise the regioselectivity (82% specificity for a 
mixture of a and b compared to 18% specificity for a mixture of 
c and d), suggesting that the affinity of the product vs reagent 
for the β-CD cavity is similar, thus poisoning the catalyst. 
 
Scheme 1. Schematic structure of the free base porphyrin-bis-cyclodextrin assembly 
and distribution of products resulting from regio/stereo selective singlet oxygen 
oxidation in aqueous media. 
In naturally occurring haemoproteins, the stability and 
reactivity of the ferrous and ferric iron core is controlled by the 
globular peptidic environment, and by the nature of the 
proximal ligand. To avoid the problem of the proximal ligand 
and its influence, as well as to enhance the reactivity of the 
metal centre, in many models the iron has been replaced by 
manganese. Taking advantage of a rather straightforward 
synthetic approach, the group of Breslow reported at the end 
of the 90s a four-fold, symmetrical, type C structure using a β-
CD and a MnTPP connected by thioether links at the p position 
of the meso aryl substituents.
18
 The scaffold mimicked the 
reactivity of cytochrome P450 and catalytically hydroxylated 
unactivated carbon atoms (ethene carbons of a 
diphenylethane derivative (top substrate, Figure 5)) in 50% 
conversion with notable regio- and stereoselectivities and 
turnovers numbers (> 600) that compare quite well with 
typical P450 enzymes. For cholesterol derivatives bearing 
protecting groups that display a high affinity for the β-CD, only 
one position was hydroxylated in the case of a rather rigid 
substrate (middle substrate, Figure 5), whereas a more flexible 
derivative (bottom substrate, Figure 5) showed multiple 
hydroxylation sites. In the case of type C structures, it is 
difficult to conclude about the binding geometry of a substrate 
when several orientations of a pseudo-linear organic structure 
can result from the binding in vicinal CDs or diametrically 
opposite CDs, depending on the substrate’s length and 
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Figure 5. A manganese porphyrin-tetra β-CD conjugate that mimics the activity of cytochrome P450 and three substrates that were each tested separately. In the case of selective 
hydroxylation, arrows indicate the reactive sites. 
flexibility. In this regard, type B structures can provide a great 
deal of information but, due to the lower symmetry of the 
porphyrin moiety, such scaffolds generally require a greater 
synthetic effort.  
These considerations probably triggered some very 
informative work by Woggon, who reported a type B Ru
II
TPP-
bis-β-CD conjugate.19 Dioxo-ruthenium porphyrins are very 
efficient oxidative catalysts and, in the enzyme model 
designed, the CD hosts are diametrically opposed at the 
periphery of the RuTPP. In this configuration, oxidative 
cleavage of β,β’-carotene compares well with the activity of 
β,β’-carotene 15,15’ dioxygenase, which produces retinal in 
approximately 25% yield. Replacement of one end group by an 
aromatic mesityl, which has a higher affinity for the CD hosts, 
renders the 15,15’ cleavage highly selective. Using scaffolds in 
which one face of the porphyrin is blocked by an inert alkyl 
strap, very convincing studies showed that the two CD hosts 
position the 15,15’ bond in the vicinity of the Ru
II
 active site.
20
   
Among the strategies and results described so far, all 
approaches involving CDs bearing only one functional group 
linked to the porphyrin are applicable to CB-porphyrin 
scaffolds using mono-functionalized CB derivatives. The 
versatility of cucurbiturils as hosts should open new avenues 
for porphyrin-CB conjugates and their use as enzyme models 
or mimics.  
Whereas an obvious synthetic drawback, mostly 
concerning the porphyrin moiety, is inherent to the covalent 
engineering of porphyrin-CD conjugates, the advantage of the 
covalent approach is that the solubility of the porphyrin in 
aqueous medium is not a prerequisite. The hydrosolubility of 
the final conjugate is provided by the CD(s). On the contrary, 
the formation of self-assembled scaffolds based on self-
assembly processes and, quite generally, hydrophobic 
interactions, requires an initial and at least partial water 
solubility of all partners. The next paragraphs will show that 
the non-covalent strategies also lead to new properties and 
control the binding on iron porphyrins that have been used in 
the literature for the fixation and transport of small exogenic 
ligands and, only recently, to catalysis. 
Non-covalent porphyrin(s)-CD(s) scaffolds 
The first trace of non-covalent interactions involving CDs and 
porphyrins dates back to the early 80s and the work of 
Tsuchida.
21 
In this seminal work, a series of N-substituted 2-
methylimidazoles, which are both good axial ligands for 
metalloporphyrins and good guests for α-CDs, were used to 
form ternary complexes of imidazole, CD and protoporphyrin 
IX (heme), as shown in Figure 6. The association constants for 
the binding of the encapsulated imidazole to the iron 
porphyrin are 15 to 30 times higher than for the same 
imidazoles in the absence of the CD. This work also mentions 
that the ternary ferrous complexes formed stable oxygen 
adducts in aqueous DMF at -30 °C. Two decades later, similar 
results were obtained with a water soluble tetrapyridinium 
porphyrin.
22
  
 
 
Figure 6. Ternary complex heme-imidazole-α-CD. 
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Another report focused on the disruption of aggregates 
observed with protoporphyrin IX and related hemes in 
aqueous solutions in the presence of α- or γ-CDs. This effect 
was assigned to hydrophobic interactions.
23
 Whereas the 
investigation of disaggregation effects of CDs on porphyrin 
arrays has been pursued over the years,
24
 the association of 
porphyrins and CDs has been investigated in-depth over the 
last decades and found to arise from a set of weak interactions 
such as hydrophobic
25,26
 and/or electrostatic interactions.
27,28
 
This association has been largely exploited for the formation of 
large supramolecular objects such as pseudo-rotaxanes,
29
 
cages
30
 and porphyrin arrays,
31
 and general reviews can be 
found in the literature.
32
 
The first relevance of self-organized, type E porphyrin-CDs 
assemblies to haemoprotein models was noted by Lawrence in 
the early 90s.
34 
Although the reported work concerned only a 
free base porphyrin bearing four protonated 
aminopropylether substituents in o positions combined with a 
methylated β-CD, several important conceptual considerations 
were provided.
33
 As shown in Figure 7, tetraphenylborate 
anions were chosen to provide steric bulk to stabilise the 
pseudorotaxane structure. The K11 and K12 values for 
methylated β-CD with tetraarylporphyrin were 7.7 x 104 and 
5.9 x 10
4
 M
-1
, respectively, in succinic acid buffer at pH 5.0 and 
60 
o
C. Lower binding constants were observed with iron(III) 
porphyrins, with K11 = 3.5 x 10
4
 and K12 = 9.0 x 10
2
 M
-1
 in citric 
buffer at pH 3.0 and 25 
o
C. In addition to the utilization of a 
methylated CD, the B(Ph)4
-
 anions also preclude the solubility 
in aqueous medium. Despite these drawbacks, emphasis was 
placed on the versatility of the synthetic methodology, which 
was foreseen as applicable to a wide range of haemoprotein 
models by changing the size and nature of the hydrophobic 
cavity to achieve hydrosolubility and modulate the heme 
model environment.  
 
Figure 7. The first self-organized porphyrin-β-CD scaffold assembled in organic 
medium. 
Around the same period, the β-CD-induced dissociation of 
µ-peroxo dimers of water-soluble tetra-sulfonated iron 
porphyrins (FeTPPS) was reported with the possibility of using 
Fe
III
TPPS in conjunction with β-CD as a paramagnetic contrast 
agent for in vivo imaging due to its particular relaxivity.
35 
Although no evidence for a type E scaffolding was presented, 
the data suggest the binding of the CDs to the phenylsulfonate 
meso substituents of the porphyrin. Since the latter work, the 
trend has shifted to the use of phenylsulfonate substituents on 
the porphyrin macrocycle because these groups provide 
hydrosolubility to the starting iron porphyrin. Interesting 
association constants (>10
4 
M
-1
) for both K11 and K12, the 
respective first and second CD binding to the FeTPPS with 
various β-CDs.36,37 For example, the iron(III) complex of FeTPPS 
showed moderate binding constants with per-O-methylated β-
cyclodextrins (TMe-β-CD) with TMe-β-CD in pure water. The 
K11 and K12 values were (2.8-3.5) x 10
5
 and (0.5-7.0) x 10
4
 M
-1
, 
respectively, in buffer solution at 25 
o
C, where these values 
were pH-dependent.
38
 For these stable 2:1 complexes, the 
axial binding to the iron core was extensively studied. It was 
shown that among a series of anions (F
-
, Cl
-
, Br
-
 and I
-
, N3
-
 and 
SCN
-
), none except fluoride would coordinate to the Fe
III
 core 
in the absence of (TMe-β-CD). In addition, in the presence of 
(TMe-β-CD), bulkier anions such as ClO4- or NO3- for example, 
would not bind to the haemoprotein model.
38
 Although the 
protonated polyamine substituents initially used in this field
30 
might not be optimal to develop interactions with CDs, they 
are probably more than suitable to interact strongly with CBs 
and offer a greater versatility versus pH variations.  
 
 
Figure 8. Porphyrin chelates obtained with bis-β-CD hosts. 
Even though the association of CDs with TPPS is in general 
strong, the relative lability of the host-guest complexes quickly 
prompted the design of CD dimers to bind hydrosoluble 
porphyrins, taking advantage of a chelating effect of the 
cyclodextrin cavities.
39
 A study using various linkers between 
two β-CDs and either tetra-phenylcarboxylate or tetra-
phenylsulfonate porphyrin derivatives showed that the binding 
constants for the 1:1 complex were significantly enhanced (> 
10
6
 M
-1
).
 
As shown in Figure 8, depending on the length of the 
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linker between the CDs, type F syn and anti complexes were 
obtained.
25 
For example, the 1:4 complex is exclusively syn 
with an association constant of ca. 10
6 
M
-1
, whereas the 2:4 
complex is a mixture of syn and anti conformations. When the 
linker joining the two β-CDs was a bipyridine, a peculiar 
(3)2:(4)2 entwined structure corresponding to a cross dimer 
(Figure 8) was observed in the presence of a zinc(II) template. 
Similar cage structures, obtained without the help of a metallic 
template, were reported later by the group of Kuroda.
30
  
Once the principles controlling the formation of self-
organised porphyrin/β-CD scaffolds were established, the 
notable breakthrough in applying these principles to the 
preparation of functional haemoprotein models was the 
design of cyclodextrin dimers in which the linker joining the 
two CDs bears a mimic of the axial ligand present in the 
natural enzymes. For many years, the group of Kano has 
developed functional haemoprotein models operating in 
water. This last section will focus on the functional scaffolds 
based on a type F structure, in which the link between the β-
CDs contains an additional function (axial ligand) required for 
the haemoprotein activity.  
 
Figure 9. Various CD dimers bearing a coordinating base in the linker joining the CD 
hosts. 
Over the years, a wide range of functionalized CD dimers 
have been prepared and studied. These structures, 
summarized in Figure 8, mainly differ by the position of the CD 
to which the axial ligand is anchored or the nature of the 
latter. In association with FeTPPS, various haemoprotein 
functions were reproduced. The first evidence of a water-
soluble type F scaffold mimicking myoglobin was reported in 
2005.
40 
In this functional model, a Fe
III
TPPS is associated with 
the CD dimer Py3CD (Figure 9) and then reduced into its Fe
II
 
derivative using sodium dithionite (Na2S2O4). The Fe
II
TPPS-
Py3CD assembly was characterised by several physical 
methods, including Raman spectroscopy, and compares well 
with natural systems in terms of oxygen affinity and stability 
against auto-oxidation, unless anions are present to induce 
degradation.
41
 The same Fe
II
TPPS-Py3CD scaffold was also 
used to generate and characterise hydroperoxoferric (Fe
III
-
OOH) derivatives, which are intermediates better known as 
Compound I in biological processes.
42
 Similarly, superoxide 
dismutase activity was reported with a Mn
II
 p-tetra(4-
pyridinium)porphyrin quaternised with adamantyl derivatives 
and combined with a CD dimer joined by a Te-Te “linker”.
43
  
To enhance the bio-inspired character of the artificial 
myoglobin model, the pyridine moiety was replaced by an 
imidazole derivative in the Im3CD cyclodextrin dimer in Figure 
9.
 44
 As a result of the enhanced pKa of the imidazole axial 
ligand bound to the Fe
II
, a much lower half-saturation pressure 
(P1/2) of 1.7 torr was observed and was 10 times smaller than 
that of the Fe
II
TPPS-Py3CD model.
45
   
 
 
Scheme 2. Assembling of a cytochrome c oxidase model using a terpyridine linker in a 
β-CD dimer. 
At the top of the list of possible applications of water-
soluble oxygen carriers, red blood cell substitutes are 
extremely motivating. The drawback of small molecular 
species like cyclodextrin dimers is their size, which will not 
prevent their excretion from living organisms. To address this 
problem, porphyrin-CD scaffolds have been associated with 
dendritic polyethylene glycol (PEG) derivatives to increase 
significantly their size while maintaining their hydro-
solubility.
46
 Depending on the generation of the dendrimer 
wrapping, the half-lives of the myoglobin models in the blood 
stream could be significantly enhanced from 0.5 hours to 5 and 
almost 13 hours for the respective 1
st
 and 2
nd
 generations of 
PEG dendrimers.  
The rapid excretion of the porphyrin-CD scaffolds may 
become advantageous if the aim is to remove small diatomic 
molecules (CO, CN
-
) from a living organism. Two such 
applications have been developed. One utilized the fixation of 
a cyanide anion to the ferric centre of the Fe
III
TPPS-Im3CD 
complex.
47
 In this case, administration of the porphyrin-CDs 
species completely reversed KCN toxicity in vitro. In vivo 
studies also showed that pre-treatment of mice with the 
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porphyrin-CDs scaffold enhanced the rate of survival after KCN 
administration and that post-treatment led to complete 
recovery, thus qualifying the Fe
III
TPPS-Im3CD model as an 
antidote for KCN poisoning. More recently, a tool for in vivo CO 
depletion was designed, taking advantage of the very high 
binding affinity of carbon monoxide for the ferrous state of 
Fe
II
TPPS-Py3CD.
48
 The ability of this scaffold to trigger a 
pseudo-knockdown of endogenous CO in animals offers a 
possible means of mediating biological functions of 
endogenous CO.
49
 
As a last example of the significant progress in the design 
of functional haemoprotein models, a chelating terpyridine 
(terpy) was chosen to link two CDs, as depicted in Scheme 2.
50
 
This strategy aims at investigating the class of heterodimetallic 
enzymes such as cytochrome c oxidase (CcO). CcO is the 
terminal enzyme in the mitochondrial respiratory chain and its 
active site contains an iron porphyrin (heme a3) and a copper 
ion (CuB). In the enzyme, the Fe
II
-Cu
I
 state binds dioxygen to 
generate a Fe
III
-O-O
-
/Cu
I
 superoxo intermediate corresponding 
to a formal two electron reduced state of dioxygen. This 
intermediate is then further reduced to two water molecules. 
With the scaffold containing the terpyridine strap, Raman 
spectroscopy characterisations of the oxygen adduct on the 
Fe
II
-Cu
I
 complex provided evidence for a model that mimics 
the superoxo state observed in natural systems.  
 
 
Figure 10. Optimized molecular structures of the FeTPPS/CuTerpyCD2 inclusion 
complexes in the Fe/Cu oxo-bridged form. Hydrogens are omitted. a) the front-facing 
phenylsulfonate group is omitted. c) thioether bridges are omitted and cyclodextrins 
are colored in light blue. Molecular mechanics calculations were carried out using 
CONFLEX/MM3 (extensive search) parameters in Scigress version 2.2.1 software 
program (Fujitsu). 
The model depicted in Scheme 2 mimics the function of the 
enzyme and catalyses the four-electron reduction of molecular 
dioxygen in water, whereas all previous models were operative 
in organic solvents or deposited onto electrodes. The 
spectroscopic studies performed on this model suggest that 
the terpy-Cu
I
 and the methoxy groups of the secondary face of 
the cyclodextrin stabilise a water molecule at low pH, or a 
hydroxide anion at higher pH, in the proximity of the superoxo 
adduct, contributing to its enhanced stability. Whereas in most 
models of CcO the oxygen adducts are readily converted to CO 
adducts upon exposure to carbon monoxide, the superoxo 
complex of the model, for which the µ-hydroxo derivative 
modelled structure is represented in Figure 10, is only 
converted to its CO analogue after ca. 30 minutes. These 
encouraging results currently stimulate the exploration of 
other bridging linkers between the two cyclodextrins in order 
to modulate and control the catalytic and electrocatalytic 
events on the iron centre of the porphyrin. 
Conclusion 
This non-exhaustive overview of research oriented towards 
enzyme mimics using porphyrins and cyclodextrin derivatives 
is intended to demonstrate the advantages of using concave 
hydrophobic hosts in combination with a catalytically active 
iron- or other metallo-porphyrin and, more generally, with any 
catalytically active molecule.  In haemoproteins, Nature, which 
achieves most processes at the most refined energy economy 
level, has embedded the heme catalytic sites into hydrophobic 
environments in which the reactivity is finely tuned by the 
distant environment of the ferric/ferrous ion core of the 
porphyrin. Cavitands, whether they are calixarenes, 
cyclodextrins or cucurbiturils, provide a unique chance to 
reproduce at the molecular scale what Nature achieves with 
globular proteins. In this regard and considering their intrinsic 
hydrosolubility, CDs and CBs appear to be perfect tools in the 
supramolecular toolbox to design new eco-friendly catalysts. 
Whereas a great deal of research in this direction concerns the 
use of CDs, CBs seem to have been underrated, probably due 
to legendary solubility and functionalisation issues. Several 
seminal recent papers have reported various methods for the 
functionalization of CBs,
51-56
 and the difficult functionalisation 
of CBs is about to become a legend. As shown by the success 
of international conferences on CBs, this chemical structure 
appears to be more and more versatile in terms of 
functionalisation and uses. This contribution hopes to point 
out opportunities of combining CBs and porphyrins that should 
not be missed.  
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